Home›Companies›Healthcare›NightWare

NightWare, Inc

Prescription sleep therapy for adults with nightmare disorder or PTSD-related nightmares.

Updated Nov 11, 2026·Latest SEC filing Mar 6, 2026·Suggest an edit

About NightWare

NightWare is a private company based in Hopkins, Minnesota. It has reported $2,501,107 raised in five offerings on Form D since May 2019. Its chief executive is Matthew Tucker.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 24, 2026Mar 6, 2026$250,000of $2.0M target1$250KEquityRule 506(b)Form D ↗
Aug 22, 2025Sep 2, 2025$1,146,107of $3.0M target18$63,673Equity, OptionsRule 506(b)Form D ↗
Jul 15, 2022Jul 27, 2022$700,000of $4.5M target6$116KEquityRule 506(b)Form D ↗
Feb 17, 2021Feb 25, 2021$100,000of $1.5M target1$100KConvertible Promissory NotesRule 506(b)Form D ↗
Apr 5, 2019May 2, 2019$305,000of $2.7M target8$38,125Equity, Series A Preferred StockRule 506(b)Form D ↗
Total, five offerings$2,501,107

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on NightWare's Form D filed Mar 6, 2026.

GH
Grady Hannah
Chief Product Officer and director
MT
Matthew Tucker
Chief Executive Officer and director
GM
Gerald Mattys
Director
Also a director at Agitated Solutions.
RN
MO
Michael Ott
Director

Earlier filings also listed Nathan Michael (executive officer and director, last listed Jul 2022) and Tom Vanderheyden (director, last listed Feb 2021).

Sources

  1. SECNightWare, Inc filing history
  2. CompanyLeadership transition